Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Aug;74(2):449–454. doi: 10.1172/JCI111441

Extended major histocompatibility complex haplotypes in type I diabetes mellitus.

D Raum, Z Awdeh, E J Yunis, C A Alper, K H Gabbay
PMCID: PMC370496  PMID: 6746903

Abstract

We have studied major histocompatibility complex markers in Caucasian patients with type I diabetes mellitus and their families. The frequencies of extended haplotypes that were composed of specific HLA-B, HLA-DR, BF, C2, C4A, and C4B allelic combinations, which occurred more commonly than expected, were compared on random diabetic and normal chromosomes in the study families. We demonstrated that all of the previously recognized increases in HLA-B8, B18, B15, DR3, and perhaps DR4 could be ascribed to the increase among diabetic haplotypes of a few extended haplotypes: [HLA B8, DR3, SC01, GLO2]; [HLA-B18, DR3, F1C30]; [HLA-B15, DR4, SC33]; and [HLA-BW38, DR4, SC21]. In fact, HLA-DR3 on nonextended haplotypes was "protective", with a relative risk considerably less than 1.0. There was a paucity or absence among diabetic patients of several extended haplotypes of normal chromosomes, notably [HLA-B7, DR2, SC31] and [HLA-BW44, DR4, SC30]. The extended haplotype [HLA-BW38, DR4, SC21] is found only in Ashkenazi Jewish patients, which suggests that extended haplotypes mark specific mutations that arise in defined ethnic groups. The data show that no known MHC allele, including HLA-DR3 and possibly HLA-DR4, is per se a marker for or itself a susceptibility gene for type I diabetes. Rather, extended haplotypes, with relatively fixed alleles, are either carriers or noncarriers of susceptibility genes for this disease. Thus, the increased frequency (association) or the decreased frequency (protection) of individual MHC alleles is largely explainable by these extended haplotypes.

Full text

PDF
449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Awdeh Z. L., Raum D. D., Yunis E. J. Extended major histocompatibility complex haplotypes in man: role of alleles analogous to murine t mutants. Clin Immunol Immunopathol. 1982 Aug;24(2):276–285. doi: 10.1016/0090-1229(82)90238-0. [DOI] [PubMed] [Google Scholar]
  2. Alper C. A., Boenisch T., Watson L. Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med. 1972 Jan;135(1):68–80. doi: 10.1084/jem.135.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alper C. A. Inherited structural polymorphism in human C2: evidence for genetic linkage between C2 and Bf. J Exp Med. 1976 Oct 1;144(4):1111–1115. doi: 10.1084/jem.144.4.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alper C. A., Raum D., Karp S., Awdeh Z. L., Yunis E. J. Serum complement 'supergenes' of the major histocompatibility complex in man (complotypes). Vox Sang. 1983;45(1):62–67. doi: 10.1111/j.1423-0410.1983.tb04124.x. [DOI] [PubMed] [Google Scholar]
  5. Awdeh Z. L., Alper C. A. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3576–3580. doi: 10.1073/pnas.77.6.3576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Awdeh Z. L., Raum D., Alper C. A. Genetic polymorphism of human complement C4 and detection of heterozygotes. Nature. 1979 Nov 8;282(5735):205–207. doi: 10.1038/282205a0. [DOI] [PubMed] [Google Scholar]
  7. Awdeh Z. L., Raum D., Yunis E. J., Alper C. A. Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. Proc Natl Acad Sci U S A. 1983 Jan;80(1):259–263. doi: 10.1073/pnas.80.1.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bodmer W. F., Bodmer J. G. Evolution and function of the HLA system. Br Med Bull. 1978 Sep;34(3):309–316. doi: 10.1093/oxfordjournals.bmb.a071518. [DOI] [PubMed] [Google Scholar]
  9. Bonné-Tamir B., Bodmer J. G., Bodmer W. F., Pickbourne P., Brautbar C., Gazit E., Nevo S., Zamir R. HLA polymorphism in Israel. 9. An overall comparative analysis. Tissue Antigens. 1978 Mar;11(3):235–250. doi: 10.1111/j.1399-0039.1978.tb01255.x. [DOI] [PubMed] [Google Scholar]
  10. Brahams D. Medicine and the law. Consent to medical treatment in prison. Lancet. 1983 Jun 4;1(8336):1269–1269. doi: 10.1016/s0140-6736(83)92711-3. [DOI] [PubMed] [Google Scholar]
  11. Contu L., Deschamps I., Lestradet H., Hors J., Schmid M., Busson M., Benajam A., Marcelli-Barge A., Dausset J. HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families. Tissue Antigens. 1982 Aug;20(2):123–140. doi: 10.1111/j.1399-0039.1982.tb00335.x. [DOI] [PubMed] [Google Scholar]
  12. Cudworth A. G. Type I diabetes mellitus. Diabetologia. 1978 May;14(5):281–291. doi: 10.1007/BF01223018. [DOI] [PubMed] [Google Scholar]
  13. Cudworth A. G., Woodrow J. C. Genetic susceptibility in diabetes mellitus: analysis of the HLA association. Br Med J. 1976 Oct 9;2(6040):846–848. doi: 10.1136/bmj.2.6040.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dausset J., Legrand L., Lepage V., Contu L., Marcelli-Barge A., Wildloecher I., Benajam A., Meo T., Degos L. A haplotype study of HLA complex with special reference to the HLA-DR series and to Bf. C2 and glyoxalase I polymorphisms. Tissue Antigens. 1978 Oct;12(4):297–307. doi: 10.1111/j.1399-0039.1978.tb01337.x. [DOI] [PubMed] [Google Scholar]
  15. Kay P. H., McCluskey J., Christiansen F. T., Feeney D., McCann V. J., Zilko P. J., Dawkins R. L., O'Neill G. J. Complement allotyping reveals new genetic markers in rheumatoid arthritis and diabetes mellitus. Tissue Antigens. 1983 Feb;21(2):159–160. doi: 10.1111/j.1399-0039.1983.tb00383.x. [DOI] [PubMed] [Google Scholar]
  16. Kirk R. L., Theophilus J., Whitehouse S., Court J., Zimmet P. Genetic susceptibility to diabetes mellitus: the distribution of properdin factor B (Bf) and glyoxalase (GLO) phenotypes. Diabetes. 1979 Oct;28(10):949–951. doi: 10.2337/diab.28.10.949. [DOI] [PubMed] [Google Scholar]
  17. Kömpf J., Bissbort S., Gussmann S., Ritter H. Polymorphism of red cell glyoxalase I (EI: 4.4.1.5); a new genetic marker in man. Investigation of 169 mother-child combinations. Humangenetik. 1975;27(2):141–143. doi: 10.1007/BF00273329. [DOI] [PubMed] [Google Scholar]
  18. Ludwig H., Schernthaner G., Mayr W. R. Letter: Is HLA-B7 a marker associated with a protective gene in juvenile-onset diabetes mellitus? N Engl J Med. 1976 May 6;294(19):1066–1066. doi: 10.1056/NEJM197605062941916. [DOI] [PubMed] [Google Scholar]
  19. Mauff G., Alper C. A., Awdeh Z., Batchelor J. R., Bertrams J., Bruun-Petersen G., Dawkins R. L., Démant P., Edwards J., Grosse-Wilde H. Statement on the nomenclature of human C4 allotypes. Immunobiology. 1983 Mar;164(2):184–191. doi: 10.1016/s0171-2985(83)80009-6. [DOI] [PubMed] [Google Scholar]
  20. McCann V. J., Davis R. E., Welborn T. A., Constable I. J., Beale D. G. Glyoxalase phenotypes in patients with diabetes mellitus. Aust N Z J Med. 1981 Aug;11(4):380–382. doi: 10.1111/j.1445-5994.1981.tb03516.x. [DOI] [PubMed] [Google Scholar]
  21. McCann V. J., McCluskey J., Kay P. H., Zilko P. J., Christiansen F. T., Dawkins R. L. HLA and complement genetic markers in diabetic retinopathy. Diabetologia. 1983 Mar;24(3):221–221. doi: 10.1007/BF00250171. [DOI] [PubMed] [Google Scholar]
  22. McCluskey J., McCann V. J., Kay P. H., Zilko P. J., Christiansen F. T., O'Neill G. J., Dawkins R. L. HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia. 1983 Mar;24(3):162–165. doi: 10.1007/BF00250155. [DOI] [PubMed] [Google Scholar]
  23. Nerup J., Platz P., Andersen O. O., Christy M., Lyngsoe J., Poulsen J. E., Ryder L. P., Nielsen L. S., Thomsen M., Svejgaard A. HL-A antigens and diabetes mellitus. Lancet. 1974 Oct 12;2(7885):864–866. doi: 10.1016/s0140-6736(74)91201-x. [DOI] [PubMed] [Google Scholar]
  24. Owerbach D., Lernmark A., Platz P., Ryder L. P., Rask L., Peterson P. A., Ludvigsson J. HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature. 1983 Jun 30;303(5920):815–817. doi: 10.1038/303815a0. [DOI] [PubMed] [Google Scholar]
  25. Raum D. D., Awdeh Z. L., Glass D., Yunis E., Alper C. A. The location of C2, C4, and BF relative to HLA-B and HLA-D. Immunogenetics. 1981 Mar 1;12(5-6):473–483. doi: 10.1007/BF01561689. [DOI] [PubMed] [Google Scholar]
  26. Raum D., Alper C. A., Stein R., Gabbay K. H. Genetic marker for insulin-dependent diabetes mellitus. Lancet. 1979 Jun 9;1(8128):1208–1210. doi: 10.1016/s0140-6736(79)91895-6. [DOI] [PubMed] [Google Scholar]
  27. Ryder L. P., Svejgaard A., Dausset J. Genetics of HLA disease association. Annu Rev Genet. 1981;15:169–187. doi: 10.1146/annurev.ge.15.120181.001125. [DOI] [PubMed] [Google Scholar]
  28. Singal D. P., Blajchman M. A. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes. 1973 Jun;22(6):429–432. doi: 10.2337/diab.22.6.429. [DOI] [PubMed] [Google Scholar]
  29. Sosenko J. M., Breslow J. L., Miettinen O. S., Gabbay K. H. Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients. N Engl J Med. 1980 Mar 20;302(12):650–654. doi: 10.1056/NEJM198003203021202. [DOI] [PubMed] [Google Scholar]
  30. Thomsen M., Platz P., Andersen O. O., Christy M., Lyngsøoe, Nerup J., Rasmussen K., Ryder L. P., Nielsen L. S., Svejgaard A. MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev. 1975;22:125–147. doi: 10.1111/j.1600-065x.1975.tb01555.x. [DOI] [PubMed] [Google Scholar]
  31. Van de Putte I., Vermylen C., Decraene P., Vlietinck R., van de Berghe H. Letter: Segregation of HLA B7 in juvenile-onset diabetes mellitus. Lancet. 1976 Jul 31;2(7979):251–251. doi: 10.1016/s0140-6736(76)91043-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES